Caesarean Delivery

Gastroenterology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AM-Pharma
AM-PharmaNetherlands - Utrecht
1 program
subcutaneous adaptionN/A1 trial
Active Trials
NCT01542346Completed

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AM-Pharmasubcutaneous adaption

Clinical Trials (1)

NCT01542346AM-Pharmasubcutaneous adaption

Subcutaneous Adaption and Cosmetic Outcome Following Caesarean Delivery

Start: Mar 2012
N/ACompleted

Related Jobs in Gastroenterology

Specialty Representative, Gastroenterology – Minneapolis, Minnesota

AbbVie
Remote
8h ago

Key Account Director, Diagnostics and Research

Tempus
Remote
21h ago
$150K - $200K/yr

Experienced Clin Programmer

Johnson & Johnson
High Wycombe, Buckinghamshire, United Kingdom
21h ago

[Innovative Medicine] Director, Government Affairs and Policy Dept., Integrated Market Access Div.

Johnson & Johnson
Chiyoda, Tokyo, Japan
21h ago

Analyst Accounting

Johnson & Johnson
Suzhou, Jiangsu, China
21h ago

Lead Product Security Engineer

Johnson & Johnson
Danvers, Massachusetts, United States of America
21h ago
$94K - $152K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Hepatic Impairment(79)Gastroesophageal Reflux Disease(37)Irritable Bowel Syndrome(29)Gastroesophageal Reflux(27)Liver Transplantation(24)Celiac Disease(23)Hepatic Insufficiency(22)Liver Cirrhosis(22)Gastroesophageal Reflux Disease (GERD)(14)Hepatic Encephalopathy(12)